A Oral Fast Dissolving Films Containing Lyophilized Labetalol HCL with Hydroxy Propyl β-Cyclodextrin/ Soluplus: Formulation Development, In Vitro Evaluation

DOI:

https://doi.org/10.37285/ijpsn.2022.15.3.7

Authors

  • NILESH KULKARNI Department of Pharmaceutics, PES Modern College of Pharmacy (For Ladies), Moshi, Pune, Maharashtra, India 412105
  • Puja Wakase Department of Pharmaceutics, PES Modern College of Pharmacy (For Ladies), Moshi, Pune, Maharashtra, India 412105
  • Pratiksha Indore Department of Pharmaceutics, PES Modern College of Pharmacy (For Ladies), Moshi, Pune, Maharashtra, India 412105
  • Shashikant Dhole Department of Pharmaceutics, PES Modern College of Pharmacy (For Ladies), Moshi, Pune, Maharashtra, India 412105

Abstract

Introduction: Labetalol HCL is an antihypertensive drug used to treat high blood pressure in the long term management of angina. Labetalol HCL is readily absorbed after oral administration. Labetalol HCl undergoes considerable hepatic first-pass metabolism due to its lipid-soluble nature. 

Objective: The drug has an absolute bioavailability of approximately 25%.  To overcome extensive hepatic first-pass metabolism the oral fast-dissolving film for labetalol HCL need to be developedLyophilized inclusion complexes of Labetalol HCL were developed with the hydrophilic carrier as Soluplus a Polyvinyl acetate polyethene glycol graft copolymer and Hydroxy Propyl β-cyclodextrin.

Experimental: Lyophilized inclusion complexes of labetalol: Soluplus and labetalol HCL: HP-β-CD were prepared with 1:0.5 weight ratios. The prepared lyophilized inclusion complexes were evaluated for solubility estimation, drug content, and In-vitro dissolution study. 

Results: The prepared inclusion complexes were characterized by Fourier transforms infrared spectroscopy and differential scanning calorimetry. Characterization of the lyophilized complex showed changed crystallinity of labetalol HCL. The fast dissolving oral film of labetalol HCL was prepared by solvent casting method by adding film-forming polymer as HPMC K 4M/ PVA in different proportions and Propylene Glycol was used as a plasticizer. The prepared batches of films were evaluated for weight variation, tensile strength, folding, endurance, disintegration time, surface pH, and drug content uniformity. All formulations prepared among F5 and F 7 showed a better result as compared to other formulations. 

Conclusion:  The study confirms the use of a lyophilized product containing Soluplus is best as that of HP-βCD for the preparation of fast dissolving film with HPMC/ PVA as film forming agent and propylene glycol as plasticizer respectively to improve dissolution rate and oral bioavailability of Labetalol HCl.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Lyophilization, Oral Film, Bioavailability, Hydroxy Propyl β-cyclodextrin, Soluplus

Downloads

Published

2022-06-30

How to Cite

1.
KULKARNI N, Wakase P, Indore P, Dhole S. A Oral Fast Dissolving Films Containing Lyophilized Labetalol HCL with Hydroxy Propyl β-Cyclodextrin/ Soluplus: Formulation Development, In Vitro Evaluation. Scopus Indexed [Internet]. 2022 Jun. 30 [cited 2024 Dec. 21];15(3). Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/2320

Issue

Section

Research Articles

References

Ali MS, Vijendar C, Sudheerkumar D and Krishnaveni J (2016). Formulation and Evaluation of Fast Dissolving Oral Films of Diazepam. J Pharmacovigil 4 (3): 1-5.

Dinge A, Nagarsenker M (2008). Formulation and Evaluation of Fast Dissolving Films for Delivery of Triclosan to the Oral Cavity. AAPS PharmSciTech 9 (2), 349-356.

E. Paul MacCarthy, M.R.C.P.I., Saul S. Bloomfield, M.D. Labetalol: A Review of Its Pharmacology, Pharmacokinetics, Clinical Uses and Adverse Effects. Pharmacotherapy. 3 (4), 1983.

Garse H, Vij M, Hirlekar R (2010). Formulation and evaluation of Gastro retentive Dosage Form of Labetalol Hydrochloride. Arch Pharm Res 33 (3), 405-410.

George SJ, Vasudevan DT (2012). Studies on The Preparation, Characterization, and Solubility of 2 HP-β-Cyclodextrin-Meclizine Hcl Inclusion Complexeses. J Young Pharm 4 (4): 220-227.

Hardikar S, Bhosale A (2018). Formulation And Evaluation of Gastro Retentive Tablets of Clarithromycin Prepared by Using Novel Polymer Blend. Bull. Fac. Pharm. Cairo Univ. 56 (2): 147–157.

Kulkarni NS, Ranpise NS, Dhole SN (2014). Physico-Chemical Evaluation and In-vitro Release Studies of Irbesartan: β-Cyclodextrin: Soluplus Ternary Inclusion Complex. Res J Pharm Technol 7 (9): 987-994.

Kulkarni NS, Gite PD, Munde MK, Dhole SN (2020). Improvement of Water Solubility And In Vitro Dissolution Rate of Deflazacort by Complexation With β-Cyclodextrin Through Freeze Drying Process. Indian drugs. 57 (7); 70-73.

Kunwarpuriya A, Doke V (2015). Formulation and Evaluation of Dextromethorphan Hydrobromide Fast Dissolving Film. Int. J. Innov. Pharm. Sci. Res. 3 (8): 2154-2347.

Mekonnen T (2016). Design and Evaluation of Fast Dissolving Buccal Films Containing Tadalafil. Int. J. Allied ed. Sci. Clin. Res. 4 (2): 155-163.

Padamwar PA (2015). Formulation and Evaluation of Fast Dissolving Oral Film of Bisoprolol Fumarate. Int. J. Pharm. Sci. Res. 6 (1): 135-142.

Patel AR, Vavia PR (2008). Preparation and Evaluation of Taste Masked Famotidine Formulation Using Drug/β-cyclodextrin/Polymer Ternary Complexation Approach. AAPS PharmSciTech. 9 (2), 544-550.

Rebecca, Ravi K, Narayana VB (2016). Formulation and in vitro Evaluation of Mouth Dissolving Tablets of Labetalol HCl by Sublimation Method. Asian J. Pharm. Tech. 6 (2): 70-80.

Rehab S., Nermeen E (2016). Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use. Drug Deliv. 23: 2, 489-499.

Reddy PS, Murthy KVR (2018). Formulation and Evaluation of Oral Fast Dissolving Films of Poorly Soluble Drug Ezetimibe Using Transcutol HP. Indian J. Pharm. Educ. Res. 52 (3): 398-407.

S. Raju, P. Sandeep Reddy, V. Anirudh Kumar, A. Deepthi, K. Sreeramulu Reddy, P.V. Madhava Reddy (2011). Flash Release Oral Films of Metoclopramide Hydrochloride for Pediatric Use: Formulation And In-Vitro Evaluation. J. Chem. Pharm. Res. 3 (4): 636-646.

Soroushnai A, Mobedi H (2018). Development and Evaluation of An Antiepileptic Oral Fast Dissolving Film with Enhanced Dissolution And In Vivo Permeation. Curr. Drug Deliv. 15 (9): 1294-1304.

Srinivasa Rao P, Rama Mohan Reddy T (2018). Development and Evaluation of Mouth Dissolving Films Containing Selegiline. Int. J. Pharm. Sci. Drug Res. 10 (4): 315-321.

Wissam SM., Khalil YI (2015). Formulation and Evaluation of Zolmitriptan Bilayer Oral Strip, World J. Pharm. Res. 4 (1): 25-57.